Ostatní
Návod 
Bio-Techne Corporation
TECH
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
9.0B
Obrat
1B
Zisk
0B
Aktiva
3B
Dluh
0B
ROE
0%
ROA
0%
PE
100
PS
7
Cena 1R
46-79
⌀ Cena
55.49
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
04-02-2026
Poslední dividenda
13-02-2026
Profil
Bio-Techne Corporation společně se svými dceřinými společnostmi vyvíjí, vyrábí a prodává činidla, nástroje a služby pro výzkum a klinickou diagnostiku po celém světě. Společnost působí ve dvou segmentech, proteinových vědách a diagnostice a genomice. Segment Protein Sciences vyvíjí a vyrábí biologická činidla používaná v různých aspektech výzkumu vědy o životě, diagnostiky a buněčné a genové terapie, jako jsou cytokiny a růstové faktory, protilátky, malé molekuly, séra tkáňových kultur a technologie selekce buněk. Tento segment také nabízí proteomické analytické nástroje pro automatizované western blot a multiplexované ELISA pracovní postupy sestávají z manuálních a automatizovaných nástrojů pro analýzu proteinů a imunotestů pro použití při kvantifikaci proteinů v různých biologických tekutinách. Segment diagnostiky a genomiky vyvíjí a vyrábí diagnostické produkty, včetně kontrol, kalibrátorů a diagnostických testů pro regulovaný trh diagnostiky, molekulárních diagnostických testů založených na exozómech, pokročilých hybridizačních testů in situ založených na tkáních pro analýzu prostorového genomu a tkáňové biopsie a genetických a onkologických souprav pro výzkum a klinické aplikace; a prodává produkty pro screening genetických nosičů, onkologickou diagnostiku, molekulární kontroly a výzkum, jakož i nástroje a produkty řízení procesů pro hematologii, chemii krve a plyny a koagulační kontroly a činidla používaná v různých diagnostických aplikacích. Své produkty nabízí pod značkami R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics a Asuragen. Společnost byla dříve známá jako Techne Corporation a v listopadu 2014 změnila svůj název na Bio-Techne Corporation. Bio-Techne Corporation byla založena v roce 1976 a sídlí v Minneapolis v Minnesotě.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
3100
Založení
1989-02-09
Podobné společnosti
$ 23.89
- $ 0.66
$ 40.25
- $ 0.56
$ 52.17
+ $ 0.71
$ 487.29
- $ 1.97
$ 69.78
- $ 0.06
$ 132.79
+ $ 1.63
$ 62.37
+ $ 1.36
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,215.6 | 1,219.6 | 1,159.1 | 1,136.7 | 1,105.6 | 931.0 | 738.7 | 714.0 | 643.0 | 563.0 | 499.0 | 452.2 | 357.8 | 310.6 | 314.6 | 290.0 | 269.0 | |
| Cost of Revenues | 422.8 | 429.4 | 389.3 | 366.9 | 349.1 | 298.2 | 255.5 | 240.5 | 210.9 | 188.5 | 162.4 | 145.0 | 106.4 | 79.5 | 78.8 | 65.0 | 54.5 | |
| Gross Profit | 792.8 | 790.3 | 769.7 | 769.8 | 756.5 | 632.9 | 483.2 | 473.5 | 432.1 | 374.5 | 336.7 | 307.3 | 251.4 | 231.1 | 235.8 | 224.9 | 214.6 |
| Revenue | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 295.9 | 286.6 | 317.0 | 316.2 | 297.0 | 289.5 | 306.1 | 303.4 | 272.6 | 276.9 | |
| Cost of Revenues | 104.6 | 98.4 | 118.2 | 101.6 | 103.1 | 106.4 | 102.8 | 98.8 | 96.0 | 91.7 | |
| Gross Profit | 191.3 | 188.1 | 198.8 | 214.6 | 193.9 | 183.0 | 203.3 | 204.6 | 176.6 | 185.2 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 92.5 | 87.1 | 70.6 | 65.2 | 62.4 | 55.3 | 53.5 | 45.2 | 40.9 | 30.9 | 29.3 | 27.9 | 26.0 | 25.1 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 378.4 | 372.8 | 325.0 | 260.6 | 264.4 | 240.6 | 199.2 | 140.9 | 119.4 | 60.7 | 43.4 | 41.7 | 35.9 | 32.2 | |
| Depreciation & Amortization | 103.7 | 109.9 | 111.7 | 107.2 | 101.1 | 87.7 | 82.7 | 78.2 | 64.5 | 60.0 | 42.8 | 37.2 | 19.2 | 12.3 | 12.5 | 8.7 | 1.0 | |
| Total Operating Expenses | 675.8 | 688.0 | 563.0 | 470.9 | 459.9 | 395.6 | 325.8 | 326.8 | 296.0 | 252.8 | 186.1 | 160.3 | 91.7 | 74.8 | 71.7 | 61.9 | 58.3 | |
| Operating Income | 117.0 | 102.3 | 206.7 | 298.9 | 296.6 | 149.5 | 74.7 | 125.6 | 136.2 | 121.8 | 150.6 | 147.0 | 159.8 | 158.5 | 166.2 | 163.1 | 156.3 |
| Operating Income | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Depreciation & Amortization | 24.7 | 24.3 | 27.1 | 27.6 | 27.1 | 28.1 | 28.1 | 27.3 | 27.8 | 28.5 | ||
| Total Operating Expenses | 136.8 | 140.5 | 222.7 | 175.8 | 146.5 | 143.0 | 157.5 | 137.6 | 138.6 | 129.3 | ||
| Operating Income | 54.5 | 47.7 | -23.9 | 38.7 | 47.4 | 40.0 | 45.8 | 67.0 | 38.0 | 55.9 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 3.5 | 3.9 | 3.3 | 3.4 | 0.8 | 0.5 | 0.6 | 0.6 | 0.4 | 0.3 | 0.2 | 0.6 | 2.7 | 2.6 | 2.6 | 3.8 | 4.4 | |
| Interest Expense | 9.3 | 8.5 | 15.7 | 11.2 | 11.3 | 14.0 | 19.2 | 21.7 | 10.2 | 7.4 | 1.7 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -2.8 | -3.8 | -21.0 | 39.7 | 4.8 | -1.4 | 201.8 | 43.5 | -10.2 | -8.6 | -3.1 | 7.1 | -1.0 | 1.7 | -4.5 | -1.8 | -4.3 | |
| IBT | 114.2 | 98.5 | 185.7 | 338.7 | 301.4 | 148.2 | 276.5 | 112.0 | 126.0 | 113.2 | 147.5 | 154.2 | 161.4 | 160.7 | 162.2 | 165.0 | 156.4 | |
| Income Tax Expense | 33.1 | 25.1 | 17.6 | 53.2 | 38.3 | 8.6 | 47.2 | 15.9 | 0.6 | 35.9 | 43.0 | 46.4 | 50.4 | 48.1 | 49.9 | 52.7 | 46.7 | |
| Net Income | 81.1 | 73.4 | 168.1 | 285.3 | 272.1 | 140.4 | 229.3 | 96.1 | 125.4 | 77.3 | 104.5 | 107.7 | 110.9 | 112.6 | 112.3 | 112.3 | 109.8 |
| Net Income | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.9 | 1.0 | 0.6 | 1.0 | 1.3 | 0.9 | 0.9 | 0.7 | 0.8 | 0.9 | ||
| Interest Expense | 2.2 | 2.9 | 2.2 | 2.0 | 2.1 | 2.2 | 2.5 | 4.0 | 4.3 | 4.9 | ||
| Other Expense | -3.7 | 0.3 | 1.0 | -0.4 | -4.5 | 0.2 | -4.2 | -5.9 | -4.6 | -6.3 | ||
| IBT | 50.8 | 48.0 | -22.9 | 38.3 | 42.9 | 40.2 | 41.7 | 61.1 | 33.4 | 49.6 | ||
| Income Tax Expense | 12.8 | 9.8 | -5.2 | 15.7 | 8.0 | 6.6 | 1.1 | 12.0 | 5.9 | -1.4 | ||
| Net Income | 38.0 | 38.2 | -17.7 | 22.6 | 34.9 | 33.6 | 40.6 | 49.1 | 27.5 | 51.0 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $1.81 | $1.73 | $0.91 | $1.50 | $0.64 | $0.84 | $0.51 | $0.70 | $0.73 | $0.75 | $0.77 | $0.76 | $0.76 | $0.74 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $1.76 | $1.66 | $0.87 | $1.46 | $0.62 | $0.83 | $0.51 | $0.70 | $0.72 | $0.75 | $0.76 | $0.76 | $0.76 | $0.74 | |
| Shares Outstanding | 155.8 | 157.5 | 157.7 | 157.2 | 156.9 | 155.0 | 152.8 | 151.1 | 149.9 | 149.3 | 148.8 | 148.4 | 147.6 | 147.3 | 147.8 | 148.4 | 149.0 | |
| Diluted Shares Outstanding | 157.0 | 159.7 | 160.8 | 161.9 | 164.1 | 161.9 | 157.6 | 155.6 | 152.2 | 150.0 | 149.3 | 148.9 | 148.0 | 147.6 | 148.0 | 148.7 | 149.4 |
| Per Share Data | TTM | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Shares Outstanding | 155.8 | 155.5 | 154.9 | 157.4 | 158.4 | 158.5 | 157.9 | 157.3 | 157.5 | 158.1 | ||
| Diluted Shares Outstanding | 157.0 | 156.4 | 155.8 | 158.9 | 160.6 | 161.1 | 160.7 | 160.5 | 160.1 | 161.9 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 151.8 | 162.2 | 151.8 | 180.6 | 172.6 | 199.1 | 146.6 | 100.9 | 122.0 | 91.6 | 64.2 | 54.5 | 318.6 | 163.8 | 116.7 | 77.6 | 98.9 | |
| Short Term Investments | 1.1 | 0.0 | 1.1 | 23.7 | 74.5 | 32.5 | 124.3 | 65.1 | 59.8 | 66.1 | 31.6 | 56.4 | 44.8 | 169.2 | 152.3 | 63.2 | 39.9 | |
| Total Cash & ST Investments | 152.9 | 162.2 | 152.9 | 204.3 | 247.0 | 231.6 | 270.9 | 166.0 | 181.8 | 157.7 | 95.8 | 110.9 | 363.4 | 332.9 | 269.0 | 140.8 | 138.8 | |
| Accounts Receivable | 241.4 | 206.9 | 241.4 | 218.5 | 194.5 | 145.4 | 122.5 | 137.5 | 120.3 | 116.8 | 93.4 | 70.0 | 47.9 | 40.2 | 37.7 | 37.9 | 32.4 | |
| Inventory | 179.7 | 189.4 | 179.7 | 171.6 | 141.1 | 116.7 | 103.2 | 91.1 | 85.6 | 60.2 | 57.1 | 49.6 | 38.8 | 34.9 | 38.3 | 44.9 | 13.7 | |
| Other Current Assets | 43.4 | 49.8 | 43.4 | 27.1 | 22.9 | 16.9 | 24.3 | 18.1 | 10.7 | 10.6 | 7.6 | 6.2 | 9.7 | 1.5 | 1.5 | 6.8 | 16.1 | |
| Total Current Assets | 617.4 | 608.3 | 617.4 | 621.5 | 605.6 | 510.6 | 520.9 | 412.6 | 398.4 | 345.3 | 253.9 | 248.3 | 469.4 | 409.5 | 346.5 | 230.4 | 201.0 |
| Current Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 145.0 | 162.2 | 140.7 | 177.5 | 187.5 | 151.8 | 139.9 | 130.1 | 148.7 | 180.6 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 5.4 | 5.5 | 0.0 | 23.7 | |
| Total Cash & ST Investments | 145.0 | 162.2 | 140.7 | 177.5 | 187.5 | 152.9 | 145.3 | 135.7 | 148.7 | 204.3 | |
| Accounts Receivable | 183.9 | 206.9 | 237.1 | 217.9 | 223.7 | 241.4 | 227.9 | 207.5 | 204.6 | 218.5 | |
| Inventory | 203.2 | 189.4 | 191.1 | 188.4 | 185.0 | 179.7 | 179.5 | 180.8 | 186.1 | 171.6 | |
| Other Current Assets | 77.5 | 49.8 | 58.3 | 50.8 | 52.3 | 43.4 | 58.0 | 66.7 | 52.2 | 27.1 | |
| Total Current Assets | 609.5 | 608.3 | 627.2 | 634.6 | 648.6 | 617.4 | 610.7 | 590.6 | 591.5 | 621.5 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 342.4 | 319.1 | 342.4 | 324.5 | 288.8 | 281.7 | 248.3 | 154.0 | 145.3 | 135.1 | 132.4 | 129.7 | 117.1 | 108.8 | 93.8 | 95.4 | 97.4 | |
| Goodwill | 972.7 | 980.9 | 972.7 | 872.7 | 822.1 | 843.1 | 728.3 | 732.7 | 597.9 | 579.0 | 430.9 | 390.6 | 151.5 | 84.3 | 85.7 | 86.6 | 25.1 | |
| Intangible Assets | 507.1 | 365.6 | 507.1 | 534.6 | 531.5 | 616.0 | 516.5 | 579.4 | 446.3 | 452.0 | 310.5 | 292.8 | 108.8 | 40.6 | 46.5 | 52.3 | 2.0 | |
| Long-Term Investments | 252.2 | 251.0 | 242.3 | -89.0 | 0.0 | -93.1 | -101.1 | -89.8 | 2.7 | 40.4 | -62.8 | -11.5 | 3.6 | 132.9 | 145.0 | 151.6 | 171.2 | |
| Other Long-Term Assets | 12.1 | 22.6 | 21.9 | 285.3 | -52.2 | 11.6 | 13.5 | 5.7 | -83.7 | -117.0 | 1.9 | 1.9 | 2.5 | -7.9 | -12.4 | -4.5 | 21.1 | |
| Total Long-Term Assets | 2,195.8 | 1,949.6 | 2,086.4 | 2,017.2 | 1,689.2 | 1,752.4 | 1,506.7 | 1,471.8 | 1,194.8 | 1,211.4 | 875.6 | 815.1 | 393.1 | 368.6 | 372.8 | 387.3 | 317.8 | |
| Total Assets | 2,813.2 | 2,557.9 | 2,703.9 | 2,638.7 | 2,294.8 | 2,263.0 | 2,027.6 | 1,884.4 | 1,593.2 | 1,556.7 | 1,129.5 | 1,063.4 | 862.5 | 778.1 | 719.3 | 617.7 | 518.8 |
| Long-Term Assets | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 311.1 | 319.1 | 335.8 | 335.1 | 343.2 | 342.4 | 341.0 | 335.1 | 334.0 | 324.5 | |
| Goodwill | 978.9 | 980.9 | 968.6 | 964.6 | 982.6 | 972.7 | 971.0 | 980.1 | 969.4 | 872.7 | |
| Intangible Assets | 350.1 | 365.6 | 443.7 | 461.1 | 486.0 | 507.1 | 526.4 | 550.6 | 579.0 | 534.6 | |
| Long-Term Investments | 266.4 | 251.0 | 254.5 | 256.4 | 256.3 | 242.3 | 248.0 | 249.7 | 251.6 | -89.0 | |
| Other Long-Term Assets | 10.2 | 22.6 | 14.5 | 18.6 | 19.4 | 21.9 | 24.2 | 24.6 | 29.9 | 285.3 | |
| Total Long-Term Assets | 1,916.6 | 1,949.6 | 2,017.1 | 2,035.8 | 2,087.5 | 2,086.4 | 2,110.5 | 2,140.1 | 2,163.9 | 2,017.2 | |
| Total Assets | 2,526.1 | 2,557.9 | 2,644.3 | 2,670.4 | 2,736.0 | 2,703.9 | 2,721.2 | 2,730.8 | 2,755.4 | 2,638.7 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 38.0 | 25.3 | 38.0 | 25.7 | 113.7 | 96.0 | 63.3 | 71.2 | 63.6 | 55.8 | 43.9 | 30.4 | 19.9 | 6.2 | 6.3 | 5.2 | 5.2 | |
| Short-Term Debt | 12.9 | 14.1 | 12.9 | 22.4 | 24.4 | 24.1 | 22.0 | 12.5 | 8.9 | 6.1 | 3.8 | 4.0 | 5.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 80.6 | 93.1 | 76.9 | 45.3 | 14.5 | 13.2 | 8.3 | 9.2 | -0.8 | 67.4 | 1.8 | 2.0 | 10.3 | 25.8 | 29.5 | 13.0 | 11.8 | |
| Current Liabilities | 159.4 | 175.8 | 159.4 | 128.5 | 176.0 | 152.3 | 106.7 | 102.0 | 78.7 | 135.4 | 54.1 | 39.8 | 26.4 | 32.1 | 35.8 | 18.2 | 17.0 |
| Current Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 30.2 | 25.3 | 31.6 | 33.1 | 31.6 | 38.0 | 28.9 | 31.5 | 28.1 | 25.7 | |
| Short-Term Debt | 13.8 | 14.1 | 14.0 | 13.5 | 13.5 | 12.9 | 13.0 | 12.7 | 12.2 | 22.4 | |
| Other Current Liabilities | 70.2 | 93.1 | 87.6 | 83.8 | 67.3 | 76.9 | 65.8 | 56.0 | 57.0 | 45.3 | |
| Current Liabilities | 144.5 | 175.8 | 169.2 | 161.3 | 142.1 | 159.4 | 149.8 | 135.2 | 127.8 | 128.5 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 319.0 | 430.0 | 406.6 | 443.8 | 301.5 | 396.5 | 411.5 | 492.7 | 339.0 | 343.8 | 130.0 | 112.0 | 7.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 87.6 | 98.1 | 100.5 | 105.0 | 70.1 | 79.2 | 76.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 165.2 | 6.2 | 55.9 | 89.0 | 99.0 | 93.1 | 101.1 | 89.8 | 86.3 | 118.0 | 62.8 | 61.4 | 33.8 | 8.5 | 9.1 | 13.4 | 0.0 | |
| Total Liabilities | 744.3 | 639.1 | 635.0 | 672.2 | 593.8 | 691.7 | 646.4 | 718.8 | 514.1 | 605.8 | 250.2 | 216.4 | 67.2 | 40.6 | 44.9 | 31.5 | 17.0 |
| Long-Term Liabilities | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 380.7 | 430.0 | 409.5 | 381.6 | 385.4 | 406.6 | 481.8 | 543.0 | 537.3 | 443.8 | |
| Capital Leases | 0.0 | 98.1 | 93.5 | 95.1 | 98.9 | 100.5 | 105.7 | 108.7 | 109.5 | 105.0 | |
| Def. Tax Liability | 11.3 | 6.2 | 31.9 | 37.7 | 50.0 | 55.9 | 63.7 | 71.6 | 83.1 | 89.0 | |
| Total Liabilities | 560.3 | 639.1 | 626.2 | 591.9 | 597.4 | 635.0 | 706.8 | 767.2 | 757.6 | 672.2 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.6 | 1.6 | 1.6 | 1.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |
| Retained Earnings | 1,325.2 | 1,066.0 | 1,325.2 | 1,309.5 | 1,122.9 | 1,085.5 | 1,057.5 | 931.9 | 876.9 | 799.0 | 770.6 | 713.9 | 653.3 | 587.7 | 520.4 | 472.7 | 400.1 | |
| Comprehensive Income | -78.3 | -59.9 | -78.3 | -66.1 | -75.2 | -57.3 | -97.2 | -83.5 | -44.8 | -48.9 | -70.4 | -30.6 | -5.4 | 14.6 | 21.8 | -16.3 | -21.2 | |
| Total Common Equity | 2,068.9 | 1,918.8 | 2,068.9 | 1,966.5 | 1,701.0 | 1,571.2 | 1,381.2 | 1,165.6 | 1,079.1 | 950.8 | 879.3 | 846.9 | 795.3 | 737.5 | 674.4 | 586.1 | 501.8 |
| Total Common Equity | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | |
| Retained Earnings | 1,082.5 | 1,066.0 | 1,196.4 | 1,286.7 | 1,341.2 | 1,325.2 | 1,297.7 | 1,261.4 | 1,327.6 | 1,309.5 | |
| Comprehensive Income | -64.4 | -59.9 | -82.1 | -85.7 | -60.1 | -78.3 | -75.3 | -63.7 | -78.0 | -66.1 | |
| Total Common Equity | 1,965.8 | 1,918.8 | 2,018.0 | 2,078.5 | 2,138.7 | 2,068.9 | 2,014.4 | 1,963.6 | 1,997.7 | 1,966.5 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 419.5 | 444.1 | 419.5 | 455.0 | 326.0 | 420.6 | 433.5 | 505.2 | 339.0 | 349.9 | 133.8 | 116.0 | 12.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 2,068.9 | 1,918.8 | 2,068.9 | 1,966.5 | 1,701.0 | 1,571.2 | 1,381.2 | 1,165.6 | 1,079.1 | 950.8 | 879.3 | 846.9 | 795.3 | 737.5 | 674.4 | 586.1 | 501.8 |
| Other | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,965.8 | 1,918.8 | 2,018.0 | 2,078.5 | 2,138.7 | 2,068.9 | 2,014.4 | 1,963.6 | 1,997.7 | 1,966.5 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 168.1 | 73.4 | 168.1 | 285.4 | 263.1 | 139.6 | 229.3 | 96.1 | 126.2 | 76.1 | 104.5 | 107.7 | 110.9 | 112.6 | 112.3 | 112.3 | 109.8 | |
| Depreciation & Amortization | 111.7 | 109.9 | 111.7 | 107.2 | 101.1 | 87.7 | 82.7 | 78.2 | 64.5 | 60.0 | 42.8 | 37.2 | 19.2 | 12.3 | 12.5 | 8.7 | 8.1 | |
| Stock-Based Compensation | 38.0 | 40.8 | 38.0 | 39.2 | 42.2 | 49.0 | 32.4 | 32.3 | 28.2 | 14.6 | 9.4 | 6.0 | 3.5 | 1.9 | 1.6 | 1.1 | 1.1 | |
| Change Working Capital | 12.0 | 11.5 | -10.1 | -48.2 | -69.5 | 29.3 | -5.2 | -27.8 | 1.9 | -13.9 | -15.0 | -11.4 | -1.8 | -5.3 | -3.9 | -0.3 | -7.8 | |
| Change In Accounts Receivable | -20.5 | 42.6 | -20.5 | -20.9 | -57.6 | -15.5 | 6.6 | -2.7 | -308.7 | -19.7 | -217.1 | -11.7 | -443.3 | -2.3 | -2.1 | -3.6 | 0.0 | |
| Change In Accounts Payable | 25.8 | -14.0 | 25.8 | -7.9 | 12.7 | 19.1 | 10.3 | 6.1 | 5.0 | 5.7 | 8.9 | 2.2 | 1.4 | 0.2 | 1.6 | -0.6 | 0.0 | |
| Change In Inventories | -8.8 | -18.1 | -14.2 | 0.4 | -32.0 | -7.1 | -14.9 | -13.6 | -13.3 | -0.7 | -6.6 | -4.7 | -2.9 | -2.2 | -1.6 | -1.0 | -2.4 | |
| Other Non-cash Items | 159.7 | 103.0 | 30.7 | -99.8 | -18.4 | 74.0 | -147.1 | 16.4 | -3.7 | 10.1 | 4.9 | -1.5 | 7.8 | 4.6 | 11.6 | 2.1 | 1.5 | |
| Cash from Operations | 299.0 | 0.0 | 0.0 | 254.4 | 325.3 | 352.2 | 205.2 | 181.6 | 170.4 | 143.4 | 143.9 | 139.4 | 136.8 | 123.6 | 126.7 | 127.2 | 111.3 |
| Cash Flow From Operating Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 38.0 | 38.2 | -17.7 | 22.6 | 34.9 | 33.6 | 40.6 | 49.1 | 27.5 | 51.0 | |
| Depreciation & Amortization | 24.7 | 24.3 | 27.1 | 27.6 | 27.1 | 28.1 | 28.1 | 27.3 | 27.8 | 28.5 | |
| Stock-Based Compensation | 14.0 | 11.7 | 4.6 | 11.4 | 0.0 | 10.2 | 7.1 | 8.1 | 12.8 | 10.1 | |
| Change Working Capital | 42.8 | -42.8 | 21.6 | -12.5 | 12.2 | -9.7 | -10.2 | 1.3 | 18.8 | -20.0 | |
| Change In Accounts Receivable | -22.4 | 22.4 | 45.2 | -15.7 | -0.6 | 21.6 | -17.9 | -22.9 | 4.7 | 15.6 | |
| Change In Accounts Payable | 2.1 | -2.1 | -13.3 | -0.6 | 10.9 | -10.9 | 18.6 | 1.8 | 8.1 | -2.7 | |
| Change In Inventories | 14.0 | -14.0 | -6.6 | 0.2 | -8.9 | 0.2 | -4.6 | 0.0 | -4.4 | -5.2 | |
| Other Non-cash Items | -37.0 | -9.0 | 94.9 | -2.5 | 18.3 | 7.0 | 19.6 | 2.7 | 7.0 | 1.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -62.9 | -31.0 | -62.9 | -38.2 | -44.9 | -44.3 | -51.7 | -25.4 | -20.9 | -15.2 | -16.9 | -19.9 | -13.8 | -22.5 | -6.0 | -3.6 | -4.6 | |
| Acquisitions | 0.0 | -15.0 | -169.7 | -315.4 | 0.0 | -225.9 | 1.9 | -289.5 | -46.3 | -293.8 | -91.4 | -420.1 | -119.2 | 1.1 | 0.5 | -131.8 | 0.0 | |
| Investments | 0.0 | -5.5 | -5.5 | -20.5 | -25.0 | -39.7 | -70.2 | -43.5 | -8.6 | -3.1 | 0.0 | 0.0 | -106.7 | -112.7 | -147.0 | -151.4 | -176.6 | |
| Sales of Investment | 36.3 | 1.1 | 28.1 | 73.2 | 26.1 | 66.4 | 147.1 | 21.6 | 36.4 | 6.1 | 0.8 | 13.5 | 289.4 | 103.6 | 131.7 | 173.5 | 66.6 | |
| Other Investing Activities | 6.1 | 0.0 | 0.0 | 35.2 | -53.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | -0.7 | -0.8 | -0.9 | 0.1 | |
| Cash from Investing | -203.0 | 0.0 | 0.0 | -265.6 | -96.9 | -243.5 | 27.1 | -336.8 | -38.7 | -306.0 | -107.6 | -426.5 | 49.7 | -31.2 | -21.7 | -114.2 | -114.6 |
| Cash Flow From Investing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -5.9 | -5.4 | -4.9 | -10.1 | -6.8 | -9.2 | -18.0 | -16.4 | -14.9 | -13.6 | |
| Acquisitions | 0.0 | 4.6 | 0.0 | 0.0 | 1.8 | -15.0 | 167.6 | 0.0 | -3.3 | -166.4 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.0 | 0.0 | -5.5 | 0.0 | |
| Sales of Investment | 0.0 | 1.4 | 0.0 | 0.0 | 0.0 | 1.1 | 9.2 | 0.0 | 5.5 | 23.8 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -256.0 | 0.0 | 0.0 | 94.0 | -175.5 | -271.5 | -188.5 | -413.5 | -59.5 | -116.5 | -58.5 | -95.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 220.6 | 24.5 | -35.4 | 223.0 | 80.9 | 258.5 | 116.9 | 579.7 | 48.6 | 332.6 | 76.2 | 198.1 | 12.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 125.9 | 0.0 | 0.0 | 0.0 | 0.0 | 321.1 | 111.0 | 618.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.3 | |
| Repurchase of Common Stock | 0.0 | -275.7 | -80.0 | -19.6 | -161.0 | -43.2 | -50.1 | -15.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.4 | -24.5 | -2.2 | -15.6 | |
| Dividends Paid | -50.4 | 0.0 | 0.0 | -50.3 | -50.2 | -49.6 | -48.9 | -48.4 | -48.0 | -47.3 | -47.6 | -47.1 | -45.4 | -43.5 | -41.0 | -39.7 | -38.4 | |
| Other Financing Activities | 158.4 | 0.0 | 0.0 | 27.4 | 143.8 | -19.3 | -7.3 | -6.3 | 8.3 | 353.2 | 83.0 | 173.3 | 8.6 | 1.2 | 0.9 | 5.6 | 0.2 | |
| Cash from Financing | -122.4 | 0.0 | 0.0 | 22.6 | -242.9 | -62.6 | -183.8 | 134.4 | -99.2 | 189.4 | -23.1 | 31.3 | -36.8 | -44.7 | -64.6 | -36.3 | -50.5 |
| Cash Flow From Financing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 394.5 | -49.6 | 20.6 | 28.4 | -3.8 | -20.6 | -75.2 | -61.0 | 6.2 | 94.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | -100.1 | -100.0 | -75.6 | 0.0 | -0.4 | 0.0 | -80.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -28.8 | 10.4 | -28.8 | 8.0 | -26.5 | 52.5 | 45.7 | -21.1 | 30.4 | 27.4 | 9.7 | -264.0 | 154.8 | 47.1 | 39.1 | -16.5 | -66.8 | |
| Closing Cash Balance | 151.8 | 162.2 | 151.8 | 180.6 | 172.6 | 199.1 | 146.6 | 100.9 | 122.0 | 91.6 | 64.2 | 54.5 | 318.6 | 163.8 | 116.7 | 77.6 | 94.1 |
| Cash position | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 27.9 | -17.2 | 21.5 | -36.9 | -10.0 | 35.7 | 11.9 | 9.8 | -18.5 | -31.9 | |
| Closing Cash Balance | 172.9 | 145.0 | 162.2 | 140.7 | 177.5 | 187.5 | 151.8 | 139.9 | 130.1 | 148.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 236.1 | 256.6 | 236.1 | 216.1 | 280.4 | 307.9 | 153.5 | 156.2 | 149.4 | 128.3 | 127.0 | 119.5 | 122.9 | 101.1 | 120.7 | 123.6 | 106.6 | |
| Real Free Cash Flow | 198.1 | 215.7 | 198.1 | 176.9 | 238.2 | 258.9 | 121.1 | 123.9 | 121.2 | 113.6 | 117.5 | 113.5 | 119.4 | 99.2 | 119.1 | 122.4 | 105.5 |
| Free Cash Flow | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 76.5 | 22.2 | 93.3 | 31.0 | 77.5 | 54.7 | 57.5 | 64.5 | 68.3 | 45.8 | |
| Real Free Cash Flow | 62.5 | 10.5 | 88.8 | 19.6 | 77.5 | 44.5 | 50.5 | 56.4 | 55.5 | 35.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 99.7 | 50.7 | -1.4 |
| P/S | 6.6 | 10.5 | 9.4 |
| P/B | 4.1 | 5.7 | 5.2 |
| P/FCF | 44.5 | 45.7 | -1.5 |
| Market cap | $9.0 | $9.1 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 12.9 % | 0 % |
| Debt to Income | 486.4 % | 191 % | 0 % |
| Debt to Free cash flow | 217.4 % | 69.9 % | 0 % |
| Interest expense percentage | 7.9 % | 4.1 % | 44.7 % |
| Current ratio | 4.2 | 7.3 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 4.1 % | 12.6 % | 0 % |
| ROA | 3.2 % | 10.1 % | 0 % |
| CapEx to Revenue | 2.2 % | 3.7 % | 0 % |
| RaD to Revenue | 0 % | 8.5 % | 0 % |
| ROEM | 392,121.6 | 320968.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 65.2 % | 69.7 % | 68.7 % |
| Operating margin | 9.6 % | 32.8 % | 35.5 % |
| Net margin | 6.7 % | 24.7 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0.9 % | 0 % |
| Dividend payout percentage | 0 % | 35.5 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 157.0 mil | 154.0 mil |
| Employee count | 3.1 tis | 1.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
